AI assistant
Thyrocare Technologies Limited — Regulatory Filings 2019
May 20, 2019
61766_rns_2019-05-20_b218a759-858b-4a2a-ba93-ef360bc07556.pdf
Regulatory Filings
Open in viewerOpens in your device viewer
==> picture [48 x 354] intentionally omitted <==
ocare· Thyr
Think Thyroid. Think Thyrocare.
May 20, 2019
The National Stock Exchange of India Limited The Bombay Stock Exchange Ltd Exchange Plaza Phiroze Jeejeeboy Towers Sandra Kurla Complex, Dalal Street, Sandra (E), Mumbai - 400 OS I Mumbai- 400 001
Dear Sir/Madam,
Sub: Disclosure of information under regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
--o--
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 20 I 5, we wish to intimate that a conference call for the Indian and overseas analysts is arranged by our management to discuss the Company's financial results for Quarter / Full Year ended March 31, 2019, on Tuesday, May 21, 2019 at 04.00 P.M. local time.
Dr. A. Velumani, Chainnan, MD & CEO, Mr. A. Sundararaju, CFO, Mr. Sachin Salvi, Vice-President- Finance, and Dr. Caesar Sengupta, Vice President- Operations, will represent the Company. Dial-in details are given in the copy of enclosed Invite of M/s. Prabhudas Lilladher, who are organizing the con-call.
Yours Faithfully,
For Thyrocare Technologies Limited,
Ramjee Dorai
Thyrocare Technologies Limited
9 0-37 /1, TTC MI DC, Turbhe, Navi Mumbai - 400 703, India (9 022- 3090 0000 / 4125 2525 II [email protected] C) www.thyrocare.com
(CIN. L85110MH2000PLC123882)
==> picture [202 x 66] intentionally omitted <==
==> picture [140 x 60] intentionally omitted <==
We cordially invite you to the Earnings Call with
Thyrocare Technologies Ltd. (THYROCAR IN)
to discuss the Q4FY19 Results
Represented by: Dr. Velumani A. PhD - CEO Mr. A. Sundararaju – CFO Mr. Sachin Salvi – VP (Finance) Dr. Caesar Sengupta – VP (Operations)
Tuesday, May 21, 2019, at 16:00 hrs IST 18:30 hrs SGT & HK / 10:30 hrs GMT / 06:30 hrs EDT / 03:30 hrs PDT
Dial-In Numbers: Universal Access Number: +91-22- 6280 1360 / 7115 8261 Local Access Number: +91-7045671221 USA: 1 866 746 2133 | UK: 0 808 101 1573 Singapore: 800 101 2045 | Hong Kong: 800 964 448
==> picture [237 x 62] intentionally omitted <==
For further information, please contact Surajit Pal | [email protected] | +91-22-6632 2259 NLatha | [email protected] | +91-22-6632 2231